CME CREDITS – Atopic Dermatitis &
Alopecia Areata MEETING

 

2026

Atopic Dermatitis & Alopecia Areata Meeting

2026

Atopic Dermatitis & Alopecia Areata Meeting

2026

Atopic Dermatitis & Alopecia Areata Meeting

This activity is supported by educational grants and/or in-kind support from Galderma Laboratories, LP.

This activity is jointly provided by Medical Education Resources and Meeting Designs, LLC

ATOPIC DERMATITIS
& ALOPECIA Meeting 2026

Rule Line

Target Audience

 

US Dermatologists, Dermatology Residents, and Dermatology Physician Extenders, HCPs involved in diagnosis and treatment of acne, rosacea and atopic dermatitis

 

Statement of Need

 

Atopic dermatitis is a common skin condition presenting to the dermatologist and alopecia areata is a distressing concern for which, up until the last two years, very few treatments existed. New therapeutic modalities for treating atopic dermatitis and alopecia areata are emerging and the dermatology clinician needs to remain current in order to optimally treat these patients. Although these are two different dermatologic conditions, new therapies that have evolved are of the similar therapeutic class for both of these medicines.

This conference will emphasize new and emerging modalities and their benefit over pre-existing treatments. There is no one treatment that is best for all patients and the differences amongst each therapeutic option will be discussed. Additionally, the expert presenters will give practical atopic dermatitis and alopecia areata management pearls so that clinicians can best care for these patients.

Typical conferences that include lectures on atopic dermatitis and alopecia areata are simply regurgitating the literature with very little time for question-and-answer periods or true experiential pearls from experts. This virtual conference will not only have an extended interactive question-and-answer period, but will also feature a discussion from the speakers about pitfalls that they have encountered in atopic dermatitis and alopecia areata management and tips for the audience to prevent them from befalling the same errors. The additions of an extended question-and-answer panel discussion, as well as the personal accounts from experts of their pitfalls, will make this a unique and sought-after conference.

This meeting will provide knowledge, but, more importantly, will give the audience access to the experts and provide an interactive forum.

 

 

 

Program Overview

 

This CME activity will educate physicians and health care workers via virtual conferencing PowerPoint presentations and panel discussions on how to diagnose, treat and manage Atopic Dermatitis patients with updated educational information for the best patient outcome.

CME Photo
CME Photo 02

Learning Outcome

 

To update training as necessary to learn how to implement safe practices into new and emerging techniques and technologies.


Earn approximately 2.25 hours of CME

Educational Objectives

After completing this activity, the participant should be better able to:

 

Implement the standard of care treatments for atopic dermatitis in adults and pediatrics

Review first-line topical treatments for atopic dermatitis

Recognize the pros and cons of different biologic medications for atopic dermatitis and their use in both adults and pediatric patients

Assess the utility of JAK inhibitor treatments for atopic dermatitis and apply learned lessons on counseling and medication management

Describe unique considerations for recognizing, diagnosing and treating atopic dermatitis in skin of color patients

Discuss alternative therapeutic approaches (e.g., laser treatment, dietary interventions) when traditional medical treatments fail

Apply learned lessons from pitfalls in atopic dermatitis management and know how to prevent such errors from occurring.

Recall the expert panel’s opinion on audience-generated questions related to atopic dermatitis.

 

 

Accreditation Statement

 

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Meeting Designs. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Credit Designation

 

Medical Education Resources designates this live activity for a maximum of approximately 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)
Credit Designation

 

Medical Education Resources designates this live activity for a maximum of 2.25 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

 

American Academy of Nurse Practitioners
(ANNP) Credit Designation

 

The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) 2.25 contact hours from activities approved by AMA, ACCME, ANCC, AANP.

 

Physician Associate Credit Designation

 

Medical Education Resources has been authorized by the American Academy of Pas (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated of approximately 2.25 AAPA Category 1 CME credits. Pas should only claim credit commensurate with the extent of their participation.